戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 us on lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis.
2 those of histiocytic human diseases, such as Langerhans cell histiocytosis.
3 ytic conditions, Erdheim-Chester disease and Langerhans cell histiocytosis.
4 lymphomas, neuroblastoma, some sarcomas, and Langerhans cell histiocytosis.
5 ues for the routine staging and diagnosis of Langerhans cell histiocytosis.
6 iterans organizing pneumonia), and pulmonary Langerhans' cell histiocytosis.
7 ng cancer and in Erdheim-Chester disease and Langerhans'-cell histiocytosis.
8                      Included among them are Langerhans cell histiocytosis and hemophagocytic lymphoh
9 hough lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis are perhaps more frequentl
10  In this study we have developed a model for Langerhans cell histiocytosis comprising a CD1a-positive
11 most common histiocytic disorders, including Langerhans cell histiocytosis, Erdheim-Chester disease,
12 s advantages in the prognosis and staging of Langerhans cell histiocytosis, in a human setting.
13 tential for the future radioimmunotherapy of Langerhans cell histiocytosis is also discussed.
14                                              Langerhans cell histiocytosis is characterized by the ab
15                                    Pulmonary Langerhans'-cell histiocytosis is an uncommon interstiti
16        The survival of adults with pulmonary Langerhans'-cell histiocytosis is shorter than that in t
17 ations have been observed in 57% of cases of Langerhans cell histiocytosis (LCH) and 54% of cases of
18  novel somatic ARAF mutation in a child with Langerhans cell histiocytosis (LCH) and demonstrate that
19 enesis of 2 of the most common histiocytoses-Langerhans cell histiocytosis (LCH) and Erdheim-Chester
20                                              Langerhans cell histiocytosis (LCH) and Erdheim-Chester
21  have been observed in half of patients with Langerhans cell histiocytosis (LCH) and in 50% to 100% o
22  heterogeneous diseases that mostly comprise Langerhans cell histiocytosis (LCH) and non-LCH.
23                                              Langerhans cell histiocytosis (LCH) and the non-LCH neop
24                Two girls were diagnosed with Langerhans cell histiocytosis (LCH) at the age of 16 and
25                                              Langerhans cell histiocytosis (LCH) combines in one noso
26                                              Langerhans cell histiocytosis (LCH) has a broad spectrum
27 nase (ERK) signaling pathway is activated in Langerhans cell histiocytosis (LCH) histiocytes, but onl
28 atients with refractory, risk-organ-positive Langerhans cell histiocytosis (LCH) in 2005.
29         There is little data on treatment of Langerhans cell histiocytosis (LCH) in adults.
30                                              Langerhans cell histiocytosis (LCH) is a clinically and
31                                              Langerhans cell histiocytosis (LCH) is a clonal disorder
32                                              Langerhans cell histiocytosis (LCH) is a myeloproliferat
33                                              Langerhans cell histiocytosis (LCH) is a rare disease af
34                                              Langerhans cell histiocytosis (LCH) is a rare disease ch
35                                              Langerhans cell histiocytosis (LCH) is a rare disease wi
36                                              Langerhans cell histiocytosis (LCH) is a rare histiocyti
37                                              Langerhans cell histiocytosis (LCH) is an enigmatic dise
38                                              Langerhans cell histiocytosis (LCH) is an inflammatory m
39                                              Langerhans cell histiocytosis (LCH) is an inflammatory m
40                                              Langerhans cell histiocytosis (LCH) is characterized by
41                                              Langerhans cell histiocytosis (LCH) represents a clonal
42                                           In Langerhans cell histiocytosis (LCH), pathologic Langerha
43                                              Langerhans cell histiocytosis (LCH), previously known as
44                                           In Langerhans cell histiocytosis (LCH), the proliferating c
45 ing data to date on a group of patients with Langerhans cell histiocytosis (LCH), which historically
46                                              Langerhans cell histiocytosis (LCH)-III tested risk-adju
47         BRAF mutations have been observed in Langerhans cell histiocytosis (LCH).
48  hypothalamopituitary axis, is documented in Langerhans cell histiocytosis (LCH).
49          An analysis of patients with proven Langerhans' cell histiocytosis (LCH) was undertaken with
50 gree of organ involvement at presentation of Langerhans' cell histiocytosis (LCH) with subsequent dis
51                                              Langerhans-cell histiocytosis (LCH) results from the acc
52                                             "Langerhans cell histiocytosis" (LCH) describes a spectru
53 mon in patients who received transplants for Langerhans cell histiocytosis relative to other indicati
54 9 patients with ECD and ECD overlapping with Langerhans cell histiocytosis (so-called mixed histiocyt
55  Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis that most commonly affects
56 n the cohort with Erdheim-Chester disease or Langerhans'-cell histiocytosis, the response rate was 43
57 with histopathologically confirmed pulmonary Langerhans'-cell histiocytosis to ascertain their vital
58  Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis, to whose pathogenesis neo
59 pendent of these risk factors, patients with Langerhans cell histiocytosis were at significantly incr
60 th survival after the diagnosis of pulmonary Langerhans'-cell histiocytosis were analyzed with the Co
61 d eruptive histiocytosis (GEH) is a rare non-Langerhans cell histiocytosis with a benign, self-healin

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。